FDA Approves Mallinckrodt’s Pennsaid For Treatment of Osteoarthritis Knee Pain

Mallinckrodt Jan. 17 announced that the Food and Drug Administration has approved Pennsaid (diclofenac sodium topical solution) 2 percent for use in the treatment of the pain of osteoarthritis of the knee.

Pennsaid 2 percent is supplied in an easy-to-use metered dose pump bottle and is applied twice each day, the Dublin-based company said. It can be applied directly to the affected knee.

“We have a diverse portfolio focused on pain management, and are committed to providing options for patients who suffer from osteoarthritis of the knee,” Mark Trudeau, chief executive officer and president of Mallinckrodt, said. “We are pleased ...